Back to resources
SIBO and SIFO: when bacterial and fungal overgrowth overlap
Small intestinal overgrowth is not always purely bacterial. Some people fit the classic SIBO pattern, some look more fungal, and many live in the gray zone where dysbiosis, motility dysfunction, low stomach acid, antibiotic history, and mixed overgrowth all feed into the same symptom picture.
Why SIBO and SIFO get confused
SIBO refers to small intestinal bacterial overgrowth. SIFO refers to small intestinal fungal overgrowth, usually involving yeast such as Candida. In real life, the distinction is not always clean. Symptoms overlap, testing is imperfect, and the underlying terrain often favors more than one kind of microbial imbalance at the same time.
That is why some people do not improve fully after a standard SIBO protocol. The bacterial part may be real, but it may not be the whole story.
A “gut overgrowth” picture is not always one organism, one test, or one protocol.
The two original newsletters made an important shared point: when bloating, gas, indigestion, fatigue, and brain fog persist despite reasonable steps, it is worth considering whether bacterial overgrowth, fungal overgrowth, or both are active together.
How they overlap and differ
| Question | SIBO | SIFO | Shared reality |
|---|---|---|---|
| What is overgrowing? | Bacteria in the small intestine in excessive amounts | Fungal organisms, often yeast, in the small intestine | Both reflect disrupted small-intestinal ecology rather than a healthy microbial distribution |
| Typical symptoms | Bloating, distension, gas, abdominal pain, diarrhea, malabsorption | Bloating, gas, abdominal discomfort, indigestion, fatigue, brain fog | The symptom profiles overlap so much that clinical confusion is common |
| Testing | Breath testing is commonly used, though imperfect | Definitive testing is invasive and not routinely done | History, pattern recognition, and response to treatment often still matter |
| What often predisposes it? | Low stomach acid, impaired motility, anatomical changes, medication effects | Antibiotic history, low stomach acid, slow motility, immune imbalance, high sugar intake | Hypochlorhydria, dysmotility, microbiome disruption, stress, and metabolic issues can support both |
| Why treatment may fail | Underlying drivers remain or relapse is not prevented | The fungal layer is missed or the terrain remains highly permissive | If the root causes stay active, the overgrowth story often repeats itself |
Common symptoms and complications
Both newsletters emphasized how non-specific these presentations can be. The core digestive symptoms are often some combination of:
- bloating and visible abdominal distension
- gas and flatulence
- abdominal pain or cramping
- indigestion and early satiety
- chronic diarrhea or bowel instability
- fatigue, weakness, and brain fog
When the problem is more longstanding, SIBO can also contribute to nutrient malabsorption and deficiencies, including magnesium, calcium, vitamin B12, and fat-soluble vitamins. The older SIBO newsletter also mentioned possible extraintestinal consequences such as anemia, neuropathic symptoms, restless legs, rosacea, weight loss, osteopenia, and broader inflammatory spillover.
SIFO is often brought into the picture when the gut symptoms are persistent, the terrain has been shaped by antibiotics or immune stress, and there is a more fungal-feeling pattern that never quite resolves through a bacteria-only lens.
Root causes and predisposing factors
The most useful way to think about both conditions is not as isolated diagnoses but as consequences of a disturbed small-intestinal environment.
Important contributors include:
- low stomach acid, including after prolonged acid-suppressing medication use
- slow gut motility and poor migrating motor complex activity
- prior or repeated antibiotic exposure
- anatomical changes, surgical history, strictures, or blind loops
- high sugar or refined carbohydrate intake in the wrong terrain
- immune dysregulation or immunodeficiency states
- diabetes, celiac disease, gastroparesis, Crohn's disease, cirrhosis, pancreatitis, scleroderma, or renal dysfunction
- stress, which can affect motility, mucosal immunity, and the overall resilience of the gut ecosystem
The deeper question is rarely “Which microbe is bad?” It is “Why did the small intestine become a place where overgrowth could persist?”
Testing limitations
Breath testing can be helpful in SIBO, but it is not a perfect mirror of what is happening inside the small intestine. Stool testing can offer clues about broader dysbiosis and fungal burden, but it is still not the same thing as directly sampling the small bowel.
The SIFO newsletter made this especially clear: the most definitive SIFO test is invasive duodenal aspirate testing, which is not something we routinely use as a first step. In practice, this means the clinical story still matters. A patient may have a mixed bacterial-fungal picture even when no single test gives a perfectly satisfying answer.
Depending on the case, I may think about breath testing, comprehensive stool analysis, organic acids, nutrient workup, and a careful history of antibiotics, acid blockers, blood sugar regulation, stress load, and dietary pattern.
How I think about treatment
The SIBO newsletter emphasized a four-part logic: identify underlying causes, reduce the overgrowth, correct deficiencies, and prevent recurrence. That logic still holds. The SIFO newsletter adds an important layer: when fungal overgrowth is likely, a bacteria-only strategy may be incomplete.
| Treatment layer | What it often includes |
|---|---|
| Address the terrain | Improve stomach acid, support motility, address medication burden, reduce inflammatory diet stressors, and understand the bigger metabolic or immune picture |
| Reduce overgrowth | Prescription agents when appropriate, or targeted herbal antimicrobials / antifungal supports such as oregano, thyme, berberine, garlic, caprylic acid, and other individualized tools |
| Correct consequences | Replete nutrient deficiencies, support gut lining repair, and help the patient tolerate food again more comfortably |
| Prevent recurrence | Motility support, better meal rhythm, ongoing dietary refinement, selective probiotics when appropriate, and continued attention to root causes |
The exact protocol should be individualized. Mixed presentations are common enough that rigid protocol thinking often underperforms.
Where low-FODMAP fits
The older SIBO newsletter rightly gave a lot of attention to low-FODMAP because certain fermentable carbohydrates can amplify bloating, gas, and abdominal pain. For some people, restricting those inputs temporarily can reduce symptom burden and make treatment more tolerable.
But low-FODMAP is not the entire answer, and it is not a forever diet. It is one tool. The deeper work is still about why the gut became so reactive to fermentation in the first place.
In SIFO-leaning cases, reducing high-sugar and refined-carbohydrate inputs can also matter, but again, diet works best when it is part of a broader plan that addresses motility, mucosal health, stress, deficiencies, and microbial balance.